نتایج جستجو برای: fluvastatin

تعداد نتایج: 698  

Journal: :Thrombosis and haemostasis 2011
Sylvie Dunoyer-Geindre Richard J Fish Egbert K O Kruithof

Statins are cholesterol-lowering drugs that exert pleiotropic effects which include changes in the plasminogen activation (PA) system of endothelial cells (EC). It was the objective of this study to investigate the signal transduction pathways by which statins increase the expression of tissue-type PA (t-PA) and decrease PA inhibitor type 1 (PAI-1) in human umbilical vein EC. Fluvastatin treatm...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2010
Junko Sugatani Satoshi Sadamitsu Masatoshi Kurosawa Shin-ichi Ikushiro Toshiyuki Sakaki Akira Ikari Masao Miwa

Rats that consumed a high-fat and high-sucrose diet (HF diet) developed hepatic steatosis. Treatment of HF diet-fed rats with fluvastatin (8 mg/kg) was lethal, followed by an elevation in levels of plasma aspartate aminotransferase and creatine kinase activities and skeletal muscle toxicity. This study was conducted to determine whether nutritional status affects statin-induced adverse effects ...

Journal: :The New England journal of medicine 2009
Olaf Schouten Eric Boersma Sanne E Hoeks Robbert Benner Hero van Urk Marc R H M van Sambeek Hence J M Verhagen Nisar A Khan Martin Dunkelgrun Jeroen J Bax Don Poldermans

BACKGROUND Adverse cardiac events are common after vascular surgery. We hypothesized that perioperative statin therapy would improve postoperative outcomes. METHODS In this double-blind, placebo-controlled trial, we randomly assigned patients who had not previously been treated with a statin to receive, in addition to a beta-blocker, either 80 mg of extended-release fluvastatin or placebo onc...

Journal: :Pharmacological reports : PR 2006
Ryszard Galus Paweł Włodarski Krzysztof H Włodarski

Several studies have demonstrated the pleiotropic effects of statins. Since Wang and associates reported that in rabbits lovastatin reduced steroid-induced bone loss, numerous authors have confirmed these data, however, others have reported conflicting results. In this study, the effects of fluvastatin on bone formation were investigated in early and late phase of osteogenesis. In the first set...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005
Hallvard Holdaas Bengt Fellström Alan G Jardine Gudrun Nyberg Carola Grönhagen-Riska Sören Madsen Hans-Hellmut Neumayer Edward Cole Bart Maes Patrice Ambühl John O Logan Beatrix Staffler Claudio Gimpelewicz

BACKGROUND Renal transplant recipients have a significantly reduced life expectancy, largely due to premature cardiovascular disease. The aim of the current analysis was to investigate the importance of time of initiation of therapy after transplantation, on the benefits of statin therapy. METHODS 2102 renal transplant recipients with total cholesterol levels of 4.0-9.0 mmol/l were randomly a...

2012
Helena Buzková Kristina Pechandová Vilém Danzig Tomáš Vařeka František Perlík Aleš Žák Ondřej Slanař

BACKGROUND CYP2C9*3 allele has been reported to correlate with increased plasma concentration of fluvastatin active form in healthy volunteers. We analyzed the correlation between the CYP2C9 genotype and cholesterol-lowering effect of fluvastatin in human hypercholesterolemic patients. MATERIAL/METHODS The study was prospective, without any interventions to standard procedures of hypolipidemi...

Journal: :The Journal of antimicrobial chemotherapy 2010
Laura Milazzo Ilaria Caramma Cristina Mazzali Miriam Cesari Micol Olivetti Massimo Galli Spinello Antinori

OBJECTIVES Recent reports demonstrated in vitro the efficacy of fluvastatin in inhibiting hepatitis C virus (HCV) replication and a synergistic effect in association with interferon-alpha (IFN-alpha). In vivo the inhibition of HCV replication by statins has not been demonstrated. We evaluated in this open-label, randomized controlled study the efficacy of fluvastatin as adjuvant to pegylated-(P...

Journal: :Folia histochemica et cytobiologica 2009
Ryszard Galus Emir Sajjad Justyna Niderla Katarzyna Borowska Krzysztof Włodarski Paweł Włodarski Jarosław Jóźwiak

Statins are widely used to lower plasma concentrations of lipids, e.g. cholesterol. One of the main effects of statin treatment is inhibition of hydroxymethyl glutaryl-coenzyme A reductase. The role of fluvastatin, a frequently used statin, was examined in potential modulation of tyrosinase (key enzyme of melanogenesis) synthesis. Levels of tyrosinase mRNA induced by UVB irradiation of B16F10 m...

Journal: :The Annals of pharmacotherapy 2005
Thomas E Delea Terry A Jacobson Patrick W J C Serruys John S Edelsberg Gerry Oster

BACKGROUND In the LIPS (Lescol Intervention Prevention Study), fluvastatin 80 mg/day reduced the risk of major adverse cardiac events (MACE) by 22% versus placebo (p = 0.01) following successful first percutaneous coronary intervention (PCI) in patients with stable or unstable angina or silent ischemia. The cost-effectiveness of such therapy is unknown. OBJECTIVE To evaluate the cost-effectiv...

Journal: :Biological & pharmaceutical bulletin 2001
S Aoki K Ikeda M Yamamura S Kojo

Fluvastatin, which is a synthetic 3-hydroxy-3-methylglutaryl coenzyme (HMG-CoA) reductase inhibitor, its metabolites (M2, M3 and M4) and trolox all inhibited the decrease of apolipoprotein B-100 (apoB) and alpha-tocopherol in a radical reaction of human plasma initiated by Cu2+. The concentrations of fluvastatin, M2, M3, M4 and trolox for 50% inhibition (IC50) of apoB fragmentation were 405, 8....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید